Evidence map›Paper›PMID 12050356›Full record

ArticleJournal of virology2002

The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors.

Dimitri Lavillette, Mariana Marin, Alessia Ruggieri, François Mallet, François-Loïc Cosset, David Kabat

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 197 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Receptor usage of Syncytin-1: ASCT2, but not ASCT1, is a functional receptor and effector of cell fusion in the human placenta.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Trophoblast Syncytialization: A Metabolic Crossroads.Results and problems in cell differentiation · 2024
    Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Dimitri LavilletteDepartment of Biochemistry and Molecular Biology, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, USA.
Mariana Marin
Alessia Ruggieri
François Mallet
François-Loïc Cosset
David Kabat
Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses · FRCentre National de la Recherche Scientifique · FRInserm · FR

Funding

NEW RETROVIRAL RECEPTORS/HOST RESISTANCESR01CA083835 · NCI · OREGON HEALTH AND SCIENCE UNIVERSITY · PI KABAT, DAVID · 2000 to 2004
$1.3M
LEUKEMOGENIC RETROVIRAL GLYCOPROTEIN: GP55-GP70SR01CA025810 · NCI · OREGON HEALTH AND SCIENCE UNIVERSITY · PI KABAT, DAVID · 1985 to 2001
$414k
NCI NIH HHS CA 25810NCI NIH HHS CA 83835NCI NIH HHS R01 CA083835
6 · The paper itself

Abstract

The human endogenous retrovirus type W (HERV-W) family includes proviruses with intact protein-coding regions that appear to be under selection pressure, suggesting that some HERV-W proviruses may remain active in higher primates. The envelope glycoprotein (Env) encoded by HERV-W is highly fusogenic, is naturally expressed in human placental syncytiatrophoblasts, and has been reported to function as a superantigen in lymphocyte cultures. Recent evidence suggested that HERV-W Env can mediate syncytium formation by interacting with the human sodium-dependent neutral amino acid transporter type 2 (hASCT2; gene name, SLC1A5) (J.-L. Blond, D. Lavillette, V. Cheynet, O. Bouton, G. Oriol, S. Chapel-Fernandez, B. Mandrand, F. Mallet, and F.-L. Cosset, J. Virol. 74:3321-3329, 2000) and that it can pseudotype human immunodeficiency virus cores (D. S. An, Y. Xie, and I. S. Y. Chen, J. Virol. 75:3488-3489, 2001). By using cell-cell fusion and pseudotype virion infection assays, we found that HERV-W Env efficiently uses both hASCT2 and the related transporter hASCT1 (gene name, SLC1A4) as receptors. In addition, although HERV-W Env mediates only slight syncytium formation or infection of mouse cells, it utilizes the mouse transporters mASCT1 and mASCT2 when their sites for N-linked glycosylation are eliminated by mutagenesis. Consistent with their role as a battlefield in host-virus coevolution, the viral recognition regions in ASCT1 and ASCT2 of humans and mice are highly divergent compared with other regions of these proteins, and their ratios of nonsynonymous to synonymous nucleotide sequence changes are extremely large. The recognition of ASCT1 and ASCT2 despite this divergence of their sequences strongly suggests that the use of both receptors has been highly advantageous for survival and evolution of the HERV-W family of retroviruses.

Indexed as

Amino Acid SequenceAmino Acid Transport System ASCAnimalsCHO CellsCricetinaeEndogenous RetrovirusesGlycoproteinsGlycosylationHumansMembrane FusionMiceMinor Histocompatibility AntigensMolecular Sequence DataMutationReceptors, VirusViral Envelope ProteinsAmino Acid Transport System ASCGlycoproteinsMinor Histocompatibility AntigensReceptors, VirusSLC1A4 protein, humanSlc1a4 protein, mouseSLC1A5 protein, humanSlc1a5 protein, mouseViral Envelope Proteins

Identifiers

PMID12050356
PMCPMC136247
OpenAlexW2172038118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.